It was found that the main cellular components of TLS were similar in every WHO classification and TNM stage, except for CD15+ TANs and FOXP3+ Tregs, which inhibited the formation of TLS in line with the low TLS density in NEC/MiNEN. The gene discussed is FOXP3; the disease is neuroendocrine carcinoma.